These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28295477)

  • 1. Erythrocytes from hereditary xerocytosis patients heterozygous for KCNN4 V282M exhibit increased spontaneous Gardos channel-like activity inhibited by senicapoc.
    Rivera A; Vandorpe DH; Shmukler BE; Gallagher DR; Fikry CC; Kuypers FA; Brugnara C; Snyder LM; Alper SL
    Am J Hematol; 2017 Jun; 92(6):E108-E110. PubMed ID: 28295477
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythrocyte ion content and dehydration modulate maximal Gardos channel activity in KCNN4 V282M/+ hereditary xerocytosis red cells.
    Rivera A; Vandorpe DH; Shmukler BE; Andolfo I; Iolascon A; Archer NM; Shabani E; Auerbach M; Hamerschlak N; Morton J; Wohlgemuth JG; Brugnara C; Snyder LM; Alper SL
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C287-C302. PubMed ID: 31091145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senicapoc: a potent candidate for the treatment of a subset of hereditary xerocytosis caused by mutations in the Gardos channel.
    Rapetti-Mauss R; Soriani O; Vinti H; Badens C; Guizouarn H
    Haematologica; 2016 Nov; 101(11):e431-e435. PubMed ID: 27443288
    [No Abstract]   [Full Text] [Related]  

  • 4. A mutation in the Gardos channel is associated with hereditary xerocytosis.
    Rapetti-Mauss R; Lacoste C; Picard V; Guitton C; Lombard E; Loosveld M; Nivaggioni V; Dasilva N; Salgado D; Desvignes JP; Béroud C; Viout P; Bernard M; Soriani O; Vinti H; Lacroze V; Feneant-Thibault M; Thuret I; Guizouarn H; Badens C
    Blood; 2015 Sep; 126(11):1273-80. PubMed ID: 26148990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell Gardos channel (KCNN4): the essential determinant of erythrocyte dehydration in hereditary xerocytosis.
    Rapetti-Mauss R; Picard V; Guitton C; Ghazal K; Proulle V; Badens C; Soriani O; Garçon L; Guizouarn H
    Haematologica; 2017 Oct; 102(10):e415-e418. PubMed ID: 28619848
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutations in the Gardos channel (KCNN4) are associated with hereditary xerocytosis.
    Glogowska E; Lezon-Geyda K; Maksimova Y; Schulz VP; Gallagher PG
    Blood; 2015 Sep; 126(11):1281-4. PubMed ID: 26198474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the potassium channel K
    Staal RGW; Khayrullina T; Zhang H; Davis S; Fallon SM; Cajina M; Nattini ME; Hu A; Zhou H; Poda SB; Zorn S; Chandrasena G; Dale E; Cambpell B; Biilmann Rønn LC; Munro G; Mӧller T
    Eur J Pharmacol; 2017 Jan; 795():1-7. PubMed ID: 27876619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis).
    Andolfo I; Russo R; Manna F; Shmukler BE; Gambale A; Vitiello G; De Rosa G; Brugnara C; Alper SL; Snyder LM; Iolascon A
    Am J Hematol; 2015 Oct; 90(10):921-6. PubMed ID: 26178367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of Asp669Tyr Piezo1 cation channel activity in red blood cells: an unexpected phenotype.
    Pérès L; Monedero Alonso D; Nudel M; Figeac M; Bruge J; Sebda S; Picard V; El Nemer W; Preudhomme C; Rose C; Egée S; Bouyer G
    Br J Haematol; 2021 Jul; 194(1):e51-e55. PubMed ID: 33973227
    [No Abstract]   [Full Text] [Related]  

  • 10. The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.
    Tubman VN; Mejia P; Shmukler BE; Bei AK; Alper SL; Mitchell JR; Brugnara C; Duraisingh MT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):613-6. PubMed ID: 26459896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydrated stomatocytic anemia due to the heterozygous mutation R2456H in the mechanosensitive cation channel PIEZO1: a case report.
    Shmukler BE; Vandorpe DH; Rivera A; Auerbach M; Brugnara C; Alper SL
    Blood Cells Mol Dis; 2014 Jan; 52(1):53-4. PubMed ID: 23973043
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and biological features in
    Picard V; Guitton C; Thuret I; Rose C; Bendelac L; Ghazal K; Aguilar-Martinez P; Badens C; Barro C; Bénéteau C; Berger C; Cathébras P; Deconinck E; Delaunay J; Durand JM; Firah N; Galactéros F; Godeau B; Jaïs X; de Jaureguiberry JP; Le Stradic C; Lifermann F; Maffre R; Morin G; Perrin J; Proulle V; Ruivard M; Toutain F; Lahary A; Garçon L
    Haematologica; 2019 Aug; 104(8):1554-1564. PubMed ID: 30655378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Gardos Channelopathy': a variant of hereditary Stomatocytosis with complex molecular regulation.
    Fermo E; Bogdanova A; Petkova-Kirova P; Zaninoni A; Marcello AP; Makhro A; Hänggi P; Hertz L; Danielczok J; Vercellati C; Mirra N; Zanella A; Cortelezzi A; Barcellini W; Kaestner L; Bianchi P
    Sci Rep; 2017 May; 7(1):1744. PubMed ID: 28496185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBCs prevent rapid PIEZO1 inactivation and expose slow deactivation as a mechanism of dehydrated hereditary stomatocytosis.
    Evans EL; Povstyan OV; De Vecchis D; Macrae F; Lichtenstein L; Futers TS; Parsonage G; Humphreys NE; Adamson A; Kalli AC; Ludlow MJ; Beech DJ
    Blood; 2020 Jul; 136(1):140-144. PubMed ID: 32305040
    [No Abstract]   [Full Text] [Related]  

  • 15. Hereditary xerocytosis: Diagnostic considerations.
    Risinger M; Glogowska E; Chonat S; Zhang K; Dagaonkar N; Joiner CH; Quinn CT; Kalfa TA; Gallagher PG
    Am J Hematol; 2018 Mar; 93(3):E67-E69. PubMed ID: 29210095
    [No Abstract]   [Full Text] [Related]  

  • 16. Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).
    Ataga KI; Reid M; Ballas SK; Yasin Z; Bigelow C; James LS; Smith WR; Galacteros F; Kutlar A; Hull JH; Stocker JW;
    Br J Haematol; 2011 Apr; 153(1):92-104. PubMed ID: 21323872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing the K
    Lee RD; Chen YJ; Nguyen HM; Singh L; Dietrich CJ; Pyles BR; Cui Y; Weinstein JR; Wulff H
    Transl Stroke Res; 2024 Jun; 15(3):518-532. PubMed ID: 37088858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemoglobin response to senicapoc in patients with sickle cell disease: a re-analysis of the Phase III trial.
    Ataga KI; Staffa SJ; Brugnara C; Stocker JW
    Br J Haematol; 2021 Mar; 192(5):e129-e132. PubMed ID: 33527340
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemoglobin C trait accentuates erythrocyte dehydration in hereditary xerocytosis.
    Yang E; Voelkel EB; Lezon-Geyda K; Schulz VP; Gallagher PG
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28121068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydrated hereditary stomatocytosis.
    Layton DM; Bain BJ
    Am J Hematol; 2016 Feb; 91(2):266. PubMed ID: 26440377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.